Filgrastim biosimilar (Laboratorios AC Farma)

非格司亭生物类似药（Laboratorios AC Farma）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Laboratorios AC Farma)
Drug Alias NameRecombinant human granulocyte macrophage colony stimulating factor (Laboratorios AC Farma)重组人粒细胞刺激因子（Laboratorios AC Farma）rhG-CSF (Laboratorios AC Farma)非格司亭生物仿制药（Laboratorios AC Farma）FGM-Factor
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryPeru
Original Approved Date2012/01/01
Country/TerritoryPeru
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Ac Farma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Ac Farma
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A